See every side of every news story
Published loading...Updated

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

Summary by Eurek Alert
Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results

4 Articles

All
Left
Center
2
Right
1
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

New York Post broke the news in New York, United States on Saturday, February 15, 2025.
Sources are mostly out of (0)

Similar News Topics